Skip to content

GPs Companies Pricing About Sign in Start free

GP Intel.

Open-data private equity intelligence. 1,000+ European PE firms, 21,000+ portfolio companies, verified exits. Finally done right.

Product

GP Database
Companies
Features
Pricing

Discover

By country
By sector
By strategy
Rankings
Blog
Glossary

Company

About
Methodology
Editorial standards
FAQ
Press
Contact

© 2026 GP Intel. All rights reserved.

Home/Companies/Healthcare/MedDay Pharmaceuticals

MP

MedDay Pharmaceuticals

Healthcare·

France·Exited 2021·Held 5yr

MedDay Pharmaceuticals is a healthcare company, headquartered in France.

Entry

2016

Hold

5yr

Exit

2021

Est. EV

–

Investor

Andera Partners

Sign in to see fund context

Key facts

HQFrance

SectorHealthcare

Small molecule for the treatment of progressive multiple sclerosis

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

More from BioDiscovery 4

Other portfolio companies in the same fund.

Autonomic Technologies

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Advent International

A Place for Mom

Last updated April 2026 · Sourced from public filings

Healthcare

US· 2015

to

Abacus Pharmaceuticals

The Carlyle Group

Abbisko Healthcare

The Carlyle GroupChina

MedDay Pharmaceuticals. Healthcare | Former Portfolio of Andera Partners (2016) | GP Intel